Bioengineers combine lab-on-a-chip technology with AI to improve cancer immunotherapy


An interdisciplinary team of researchers led by Indiana University bioengineer Feng Guo has developed a tool that could lead to improved cancer immunotherapy. The prototype platform facilitates automated drug screening and real-time, 3D imaging and analysis of interactions between immune cells and cancer cells. The team’s findings were recently published in Proceedings of the National Academy of Sciences.

Best dating sites for men: Whether you’re looking to hook up, find love, or something in between

Previous article

Swelling along brain’s axons may be true culprit in Alzheimer’s disease

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations